PMDA inspection
Lishizen Road Site: Boehringer Ingelheim Biopharmaceuticals (China) Ltd.
PMDA inspection 5130608033882 · China · Suitable
Key facts
| Control number | 5130608033882 |
|---|---|
| Manufacturing site | Lishizen Road Site: Boehringer Ingelheim Biopharmaceuticals (China) Ltd. |
| Location | 257, Lishizen Road, Pilot Free Trade Zone, Shanghai, 201203 China (CHN) |
| Country | China |
| Product type | Pharmaceuticals |
| Application type | New |
| Inspection method | Remote |
| Inspection month | Nov 1, 2024 |
| Result | Suitable |
| Result notified | Nov 8, 2024 |
| PMDA registration | AG10500831 |
| FEI numbers | 3015009021 |
About PMDA GMP inspections (Japan)
Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan